COMPUTED DESCRIPTORS
| Molecular Weight | 529.16 g/mol |
|---|---|
| XLogP3 | -5.7 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 9 |
| Exact Mass | 528.97000594 g/mol |
| Monoisotopic Mass | 528.97000594 g/mol |
| Topological Polar Surface Area | 285 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 995 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Favipiravir-RTP is a nuceloside analogue in which the nucleobase is favipiravir. It is a RNA-dependent RNA polymerase inhibitor which exhibits anti-influenza and anti-coronaviral activities. It has a role as an anticoronaviral agent, an antiviral drug and an EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor. It is a primary carboxamide, an organofluorine compound, a nucleoside analogue, an organic triphosphate and a pyrazinone. It is functionally related to a favipiravir.